Skip to content

Author

B. Satirapoj

We have 2 of 159 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Combination Kidney-Protective Therapy in Diabetic Kidney Disease: From RAAS Blockade to Multidrug Precision Nephrology

This review summarizes current and emerging evidence supporting combination kidney-protective therapy in DKD, including RAAS inhibitors, sodium-glucose cotransporter-2 (SGLT2) inhibitors, finerenone, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), endothelin receptor antagonists, and aldosterone synthase inhibit...

B. Satirapoj · 0 citations
Open access Sep 2026

Effect of Hydroxychloroquine on Proteinuria and Inflammatory Markers in Chronic Glomerulopathy: A Proof-of-Concept Randomized Controlled Trial (HCQ-CGN Trial)

Abstract Introduction Hydroxychloroquine (HCQ) has immunomodulatory and anti-inflammatory properties that may provide additional benefit in chronic proteinuric glomerulopathy (CGN). This study aimed to evaluate the short-term effects of adjunctive HCQ on proteinuria and inflammatory biomarkers in patients with stable C...

Thitirat Supasil, P. Thimachai, O. Supasyndh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.